Retraction

撤稿声明: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma (vol 55, pg 617, 2020) (Retraction of Vol 55, Pg 517, 2020)

Journal

CNS NEUROSCIENCE & THERAPEUTICS
Volume 26, Issue 7, Pages 777-+

Publisher

WILEY
DOI: 10.1111/cns.13227

Keywords

-

Funding

  1. National Natural Science Foundation of China [81802502]
  2. Natural Science Basic Research Plan in Shaanxi Province of China [2019JQ-958]
  3. Fundamental Research Funds of Xi'an Jiaotong University [1191329177]
  4. Special Foundation for Class A Subject of the First Affiliated Hospital of Xi'an Jiaotong University

Ask authors/readers for more resources

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (). The above article published online on 02 October 2019 in Wiley Online Library (), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available